Showing results (2211-2220 of 2,341) with videos related to

Sort By:
Pageof 235
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 18, 2013
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophreniaL Fredrik Jarskog, Zhengchao Dong, Alayar Kangarlu, et al.
Neurology|August 22, 2022
Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S VariantRachel Saunders-Pullman, Roberto Angel Ortega, Cuiling Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 31, 2015
Hybrid Organic-Inorganic Perovskites (HOIPs): Opportunities and ChallengesJoseph Berry, Tonio Buonassisi, David A Egger, et al.
Psychiatry Research|August 18, 2015
The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerationsSomaia Mohamed, Gary R Johnson, Julia E Vertrees, et al.
Rheumatology (Oxford, England)|September 2, 2024
Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Didem Saygin, et al.
Nature Chemistry|October 25, 2024
Remote chirality transfer in low-dimensional hybrid metal halide semiconductorsMd Azimul Haque, Andrew Grieder, Steven P Harvey, et al.
Neurobiology of Disease|January 26, 2018
Alpha galactosidase A activity in Parkinson's diseaseR N Alcalay, P Wolf, O A Levy, et al.
Pageof 235